71 related articles for article (PubMed ID: 23578236)
1. Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
Tomlins SA; Alshalalfa M; Davicioni E; Erho N; Yousefi K; Zhao S; Haddad Z; Den RB; Dicker AP; Trock BJ; DeMarzo AM; Ross AE; Schaeffer EM; Klein EA; Magi-Galluzzi C; Karnes RJ; Jenkins RB; Feng FY
Eur Urol; 2015 Oct; 68(4):555-67. PubMed ID: 25964175
[TBL] [Abstract][Full Text] [Related]
2. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
[TBL] [Abstract][Full Text] [Related]
3. Induced chromosomal proximity and gene fusions in prostate cancer.
Mani RS; Tomlins SA; Callahan K; Ghosh A; Nyati MK; Varambally S; Palanisamy N; Chinnaiyan AM
Science; 2009 Nov; 326(5957):1230. PubMed ID: 19933109
[TBL] [Abstract][Full Text] [Related]
4. TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences.
Zhou CK; Young D; Yeboah ED; Coburn SB; Tettey Y; Biritwum RB; Adjei AA; Tay E; Niwa S; Truelove A; Welsh J; Mensah JE; Hoover RN; Sesterhenn IA; Hsing AW; Srivastava S; Cook MB
Am J Epidemiol; 2017 Dec; 186(12):1352-1361. PubMed ID: 28633309
[TBL] [Abstract][Full Text] [Related]
5. ERG oncogene modulates prostaglandin signaling in prostate cancer cells.
Mohamed AA; Tan SH; Sun C; Shaheduzzaman S; Hu Y; Petrovics G; Chen Y; Sesterhenn IA; Li H; Sreenath T; McLeod DG; Dobi A; Srivastava S
Cancer Biol Ther; 2011 Feb; 11(4):410-7. PubMed ID: 21178489
[TBL] [Abstract][Full Text] [Related]
6. Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.
Rao SR; Alham NK; Upton E; McIntyre S; Bryant RJ; Cerundolo L; Bowes E; Jones S; Browne M; Mills I; Lamb A; Tomlinson I; Wedge D; Browning L; Sirinukunwattana K; Palles C; Hamdy FC; Rittscher J; Verrill C
J Mol Diagn; 2020 May; 22(5):652-669. PubMed ID: 32229180
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ERG responsive proteome in prostate cancer.
Tan SH; Furusato B; Fang X; He F; Mohamed AA; Griner NB; Sood K; Saxena S; Katta S; Young D; Chen Y; Sreenath T; Petrovics G; Dobi A; McLeod DG; Sesterhenn IA; Saxena S; Srivastava S
Prostate; 2014 Jan; 74(1):70-89. PubMed ID: 24115221
[TBL] [Abstract][Full Text] [Related]
8. No differences in miRNA expression in the stroma of ERG+ and ERG- prostate cancers.
Wątor G; Kołton-Wróż M; Wołkow P; Bełch Ł; Chłosta P; Szpor J; Klimkowska A; Nejman K; Józkowicz A; Piechota-Polańczyk A; Okoń K
Pol J Pathol; 2023; 74(4):265-270. PubMed ID: 38477088
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.
Wyatt AW; Mo F; Wang K; McConeghy B; Brahmbhatt S; Jong L; Mitchell DM; Johnston RL; Haegert A; Li E; Liew J; Yeung J; Shrestha R; Lapuk AV; McPherson A; Shukin R; Bell RH; Anderson S; Bishop J; Hurtado-Coll A; Xiao H; Chinnaiyan AM; Mehra R; Lin D; Wang Y; Fazli L; Gleave ME; Volik SV; Collins CC
Genome Biol; 2014 Aug; 15(8):426. PubMed ID: 25155515
[TBL] [Abstract][Full Text] [Related]
10. Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.
Testa U; Castelli G; Pelosi E
Medicines (Basel); 2019 Jul; 6(3):. PubMed ID: 31366128
[TBL] [Abstract][Full Text] [Related]
11. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.
Ornish D; Magbanua MJ; Weidner G; Weinberg V; Kemp C; Green C; Mattie MD; Marlin R; Simko J; Shinohara K; Haqq CM; Carroll PR
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8369-74. PubMed ID: 18559852
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathology of Prostate Cancer.
Kulac I; Roudier MP; Haffner MC
Clin Lab Med; 2024 Jun; 44(2):161-180. PubMed ID: 38821639
[TBL] [Abstract][Full Text] [Related]
13. cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression.
Gulliver C; Busiau T; Byrne A; Findlay JE; Hoffmann R; Baillie GS
Mol Oncol; 2024 Mar; 18(3):707-725. PubMed ID: 38126155
[TBL] [Abstract][Full Text] [Related]
14. ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.
Hernández-Llodrà S; Juanpere N; de Muga S; Lorenzo M; Gil J; Font-Tello A; Agell L; Albero-González R; Segalés L; Merino J; Serrano L; Fumadó L; Cecchini L; Lloreta-Trull J
Oncotarget; 2017 Sep; 8(43):74106-74118. PubMed ID: 29088771
[No Abstract] [Full Text] [Related]
15. Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.
Geybels MS; Alumkal JJ; Luedeke M; Rinckleb A; Zhao S; Shui IM; Bibikova M; Klotzle B; van den Brandt PA; Ostrander EA; Fan JB; Feng Z; Maier C; Stanford JL
Clin Epigenetics; 2015; 7():128. PubMed ID: 26692910
[TBL] [Abstract][Full Text] [Related]
16. High-resolution ERG-expression profiling on GeneChip exon 1.0 ST arrays in primary and castration-resistant prostate cancer.
Smit FP; Salagierski M; Jannink S; Schalken JA
BJU Int; 2013 May; 111(5):836-42. PubMed ID: 23578236
[TBL] [Abstract][Full Text] [Related]
17. Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays.
Jhavar S; Reid A; Clark J; Kote-Jarai Z; Christmas T; Thompson A; Woodhouse C; Ogden C; Fisher C; Corbishley C; De-Bono J; Eeles R; Brewer D; Cooper C
J Mol Diagn; 2008 Jan; 10(1):50-7. PubMed ID: 18165275
[TBL] [Abstract][Full Text] [Related]
18. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
Hermans KG; van Marion R; van Dekken H; Jenster G; van Weerden WM; Trapman J
Cancer Res; 2006 Nov; 66(22):10658-63. PubMed ID: 17108102
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.
Laxman B; Tomlins SA; Mehra R; Morris DS; Wang L; Helgeson BE; Shah RB; Rubin MA; Wei JT; Chinnaiyan AM
Neoplasia; 2006 Oct; 8(10):885-8. PubMed ID: 17059688
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
